0000014272-17-000065.txt : 20170307
0000014272-17-000065.hdr.sgml : 20170307
20170307163933
ACCESSION NUMBER: 0000014272-17-000065
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170303
FILED AS OF DATE: 20170307
DATE AS OF CHANGE: 20170307
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO
CENTRAL INDEX KEY: 0000014272
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 220790350
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 345 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10154
BUSINESS PHONE: 2125464000
MAIL ADDRESS:
STREET 1: 345 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10154
FORMER COMPANY:
FORMER CONFORMED NAME: BRISTOL MYERS CO
DATE OF NAME CHANGE: 19891012
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEUNG SANDRA
CENTRAL INDEX KEY: 0001199294
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-01136
FILM NUMBER: 17672483
MAIL ADDRESS:
STREET 1: C/O BRISTOL MYERS SQUIBB CO
STREET 2: 345 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10164
4
1
wf-form4_148892276044701.xml
FORM 4
X0306
4
2017-03-03
0
0000014272
BRISTOL MYERS SQUIBB CO
BMY
0001199294
LEUNG SANDRA
BRISTOL-MYERS SQUIBB COMPANY
345 PARK AVENUE
NEW YORK
NY
10154
0
1
0
0
EVP, General Counsel
Common Stock, $0.10 par value
2017-03-03
4
M
0
116100
27.01
A
488063.3322
D
Common Stock, $0.10 par value
2017-03-06
4
S
0
92405
57.016
D
395658.3322
D
Common Stock, $0.10 par value
5847.1498
I
By BMY Savings and Investment Program
Option (right to buy)
27.01
2017-03-03
4
M
0
116100
0
D
2017-03-05
Common Stock, $0.10 par value
116100.0
0
D
A portion of the proceeds from the sale of these shares were used to cover the exercise price and taxes of the Option exercised on March 3, 2017. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $56.64 to $57.22, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
Based on a plan statement as of the end of the most recent fiscal quarter.
All of the shares are currently exercisable.
/s/ Katherine Kelly, attorney-in-fact for Sandra Leung
2017-03-07